Vicapsys Life Sciences, Inc. SEC filings VICP

Vicapsys Life Sciences, Inc. has 92 filings in SEC EDGAR's recent list, going back to Jul 17, 2009. Its latest annual report, Form 10-K, was filed on Oct 21, 2024 for the period ended Dec 31, 2023. The latest quarterly report (Form 10-Q) was filed on Jan 10, 2025, covering the quarter ended Sep 30, 2024. The most recent current report (Form 8-K) was filed on Dec 27, 2023 (material agreement, new debt). The company's fiscal year ends on December 31.

Vicapsys Life Sciences, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Jan 10, 2025 Sep 30, 2024
10-Q Quarterly report Jan 10, 2025 Jun 30, 2024
10-Q Quarterly report Jan 10, 2025 Mar 31, 2024
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Nov 21, 2022 Sep 30, 2022
10-Q Quarterly report Aug 16, 2022 Jun 30, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
10-Q Quarterly report Sep 20, 2021 Jun 30, 2021
10-Q Quarterly report Sep 20, 2021 Mar 31, 2021
10-Q Quarterly report Sep 13, 2021 Sep 30, 2020
10-Q Quarterly report Sep 9, 2021 Jun 30, 2020
10-Q Quarterly report May 15, 2020 Mar 31, 2020
10-Q Quarterly report Aug 24, 2010 Jun 30, 2010
10-Q Quarterly report Jun 22, 2010 Mar 31, 2010

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VICP (OTC)
Fiscal year ends
December 31
Incorporated in
FL
Headquarters
Cumming, GA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1468639
Former names
SSGI, INC. (until Nov 7, 2016)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.